GLMD

Galmed Pharmaceuticals Ltd. GLMD

GLMD
Galmed Pharmaceuticals Ltd. BIVI
BioVie Inc. TOVX
Theriva Biologics, Inc. MLEC
Moolec Science S.A. CMMB
Chemomab Therapeutics Ltd. INM
InMed Pharmaceuticals Inc. BDRX
Biodexa Pharmaceuticals Plc VRAX
Virax Biolabs Group Limited ELAB
PMGC Holdings Inc. ISPC
iSpecimen Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GLMD BIVI TOVX MLEC CMMB INM BDRX VRAX ELAB ISPC
6M -54.43 % -86.50 % -54.43 % -95.21 % -58.96 % -48.19 % -61.14 % -50.16 % -68.65 % -60.07 %
YTD -74.33 % -93.62 % -88.06 % -96.05 % -76.88 % -73.13 % -91.76 % -82.10 % -96.28 % -86.16 %
1Y -71.88 % -93.25 % -84.85 % -95.96 % -70.15 % -72.44 % -91.18 % -79.39 % -96.47 % -86.31 %
3Y -99.20 % -99.80 % -98.03 % -96.57 % -78.59 % -95.87 % -99.99 % -93.12 % -99.99 % -98.51 %
5Y -99.87 % -99.91 % -99.78 % -96.69 % -98.61 % -99.92 % -100.00 % -99.78 % -99.99 % -99.73 %
10Y -99.94 % -99.07 % -100.00 % -96.69 % -99.71 % -99.93 % -100.00 % -99.78 % -99.99 % -99.73 %
From the beginning -99.97 % -99.63 % -100.00 % -96.69 % -99.71 % -99.97 % -100.00 % -99.78 % -99.99 % -99.73 %

Dividend